S2Medical AB (publ) publishes EU-growth prospectus in connection with the forthcoming rights issue of units
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. S2Medical AB (publ) ("S2Medical" or the "Company") publishes an EU-growth prospectus (the “Prospectus”) in connection with the rights issue of units resolved by the board of directors on 15 March 2022 and approved by the